The most stable regulatory peptides (RP) including the new family of RP (glyprolines) and derivatives of hybrid peptide MEHFPGP are characterized. High ability of glyprolines to penetrate into the blood-stream through the gastrointestinal tract is demonstrated. Antiulcer, antithrombotic and antidiabetic activities of glyprolines were discovered in experiments on white rats. The activity of oligopeptides PGP, PG and GP is compared. Mechanisms of glycoprolines activities and feasibility of their administration with connective tissue food proteins are discussed. Thus, glyprolines are perspective drugs for treatment of gastric ulcer, correction of hemostasis and thrombosis suppression prepared for preclinical trial.
Authors
Ashmarin, I P; Bakaeva, Z V; Vas'kovskiĭ, B V; Zheliaznik, N Ia; Zhuĭkova, S E; Zolotarev, Iu A; Kamenskiĭ, A A; Levitskaia, N G; Liapina, L A; Miasoedov, N F